过度饮酒是阿尔茨海默病的危险因素:流行病学和临床前证据
Paige E Anton1,2, Nicole M Maphis3, David N Linsenbardt3
1Bowles Center for Alcohol Studies, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Advances in experimental medicine and biology
|March 25, 2025
概括
酒精使用可能会加速阿尔茨海默病 (AD) 病理和痴呆症进展. 跨年龄组的酒精消费增加与阿尔茨海默病率的上升并行,这表明需要进一步研究的重要联系.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 成 药物 药物 药物 药物
背景情况:
- 酒精使用是阿尔茨海默病 (AD) 的新兴可修改的风险因素.
- 与酒精和AD病变发生有关的特定神经生物学机制尚未得到充分理解.
- 所有年龄组的酒精消费率的上升与阿尔茨海默症患病率的增加相吻合.
研究的目的:
- 审查支持酒精和AD相互作用的流行病学和临床前证据.
- 假设酒精使用如何影响AD病理积累和痴呆症进展.
- 为了确定酒精使用障碍和AD之间的共同生物学途径.
主要方法:
- 对有关酒精消费和AD的流行病学研究的文献综述.
- 对研究酒精对AD相关病理学影响的临床前研究进行审查.
- 分析酒精使用障碍和AD之间共享的生物机制.
主要成果:
- 流行病学数据显示,一生中酒精消费量增加,与阿尔茨海默病率上升相关.
- 酒精消费可能会加快AD相关的病理在prodromal阶段.
- 酒精使用可能会加剧痴呆症的发病和进展.
结论:
- 酒精使用是阿尔茨海默病的重要,潜在的可修改风险因素.
- 共同的生物通路包括氧化应激,神经炎症,新陈代谢,病和神经元刺激性.
- 未来的研究应该将酒精使用评估纳入阿尔茨海默氏症研究,并利用晚发性阿尔茨海默氏症 (LOAD) 的改进动物模型.
相关概念视频
CNS Depressants: Alcohol and Nicotine
164
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
164
Alzheimer's Disease: Overview
399
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
399
Alzheimer's Disease: Treatment
137
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
137
Role of Neurotransmitters in Memory
351
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
351
Dementia
78
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
78
Psychoneuroimmunology: Diabetes and Cancer
20
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
20


